Identification of <i>N</i>,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase InhibitorMaria Gabriella Brasca, Marina Ciomei, Ciro Mercurio et al.|Journal of Medicinal Chemistry|2009Cited by 128
Optimization of Diarylthiazole B‐Raf Inhibitors: Identification of a Compound Endowed with High Oral Antitumor Activity, Mitigated hERG Inhibition, and Low Paradoxical EffectMaurizio Pulici, Marina Ciomei, Gabriella Traquandi et al.|ChemMedChem|2014Cited by 9
Abstract 2522: Identification and characterization of new highly selective and potent BRAF inhibitorsMaurizio Pulici, Marina Ciomei, Nadia Amboldi et al.|Cancer Research|2010Cited by 0
Abstract 3754: Characterization of NMS-P285, a new highly selective and potent BRAF inhibitorMaurizio Pulici, Marina Ciomei, Nadia Amboldi et al.|Cancer Research|2012Cited by 0
B-Raf Kinase V600E mutant in complex with a diarylthiazole B-Raf InhibitorElena Casale, Marina Ciomei, Marina Fasolini et al.|Unknown|2014Cited by 0